Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Respiratory Tract Infections | 34 | 2019 | 961 | 2.040 |
Why?
|
Respiratory Syncytial Viruses | 42 | 2000 | 165 | 1.590 |
Why?
|
Infectious Disease Transmission, Vertical | 38 | 2017 | 1320 | 1.570 |
Why?
|
Coronavirus | 5 | 2013 | 158 | 1.520 |
Why?
|
Respirovirus Infections | 24 | 1993 | 50 | 1.410 |
Why?
|
HIV Infections | 82 | 2017 | 16718 | 1.110 |
Why?
|
Zidovudine | 28 | 2016 | 620 | 1.020 |
Why?
|
Common Cold | 2 | 2022 | 61 | 0.980 |
Why?
|
Paramyxoviridae Infections | 10 | 2004 | 55 | 0.910 |
Why?
|
HIV-1 | 49 | 2010 | 6938 | 0.900 |
Why?
|
Anti-HIV Agents | 35 | 2017 | 4256 | 0.810 |
Why?
|
Pregnancy Complications, Infectious | 27 | 2017 | 2026 | 0.710 |
Why?
|
AIDS-Related Opportunistic Infections | 6 | 2004 | 657 | 0.620 |
Why?
|
Antigens, Viral | 21 | 1999 | 1035 | 0.520 |
Why?
|
Coronavirus Infections | 5 | 2013 | 3132 | 0.520 |
Why?
|
Acquired Immunodeficiency Syndrome | 18 | 2006 | 2234 | 0.510 |
Why?
|
Pneumonia | 8 | 2019 | 2134 | 0.480 |
Why?
|
Antiretroviral Therapy, Highly Active | 13 | 2013 | 1873 | 0.460 |
Why?
|
Infant | 104 | 2017 | 35129 | 0.440 |
Why?
|
Viral Tropism | 1 | 2013 | 101 | 0.430 |
Why?
|
RNA, Viral | 23 | 2010 | 2902 | 0.430 |
Why?
|
HIV Core Protein p24 | 10 | 2003 | 256 | 0.390 |
Why?
|
Severe Acute Respiratory Syndrome | 3 | 2013 | 137 | 0.370 |
Why?
|
CD4 Lymphocyte Count | 22 | 2013 | 2559 | 0.370 |
Why?
|
HIV Protease Inhibitors | 6 | 2005 | 430 | 0.370 |
Why?
|
Reverse Transcriptase Inhibitors | 7 | 2010 | 615 | 0.360 |
Why?
|
Nevirapine | 6 | 2015 | 267 | 0.350 |
Why?
|
Viral Load | 20 | 2013 | 3300 | 0.350 |
Why?
|
HIV | 6 | 2001 | 1604 | 0.350 |
Why?
|
Coronaviridae | 6 | 2004 | 13 | 0.350 |
Why?
|
Virus Diseases | 16 | 1984 | 711 | 0.330 |
Why?
|
HIV Seropositivity | 9 | 2000 | 971 | 0.320 |
Why?
|
Ritonavir | 4 | 2005 | 322 | 0.310 |
Why?
|
Infant, Newborn | 57 | 2017 | 25618 | 0.310 |
Why?
|
Coronaviridae Infections | 3 | 2004 | 10 | 0.300 |
Why?
|
CD8-Positive T-Lymphocytes | 9 | 2009 | 4477 | 0.300 |
Why?
|
Bocavirus | 1 | 2006 | 1 | 0.300 |
Why?
|
Parainfluenza Virus 1, Human | 4 | 1992 | 28 | 0.280 |
Why?
|
Central Nervous System Diseases | 2 | 2009 | 518 | 0.270 |
Why?
|
Child, Preschool | 77 | 2010 | 40992 | 0.270 |
Why?
|
Dapsone | 3 | 2001 | 54 | 0.260 |
Why?
|
Viremia | 5 | 2006 | 736 | 0.260 |
Why?
|
T-Lymphocytes, Cytotoxic | 9 | 2005 | 1821 | 0.250 |
Why?
|
Antibodies, Viral | 30 | 1999 | 3176 | 0.250 |
Why?
|
Stavudine | 4 | 2010 | 85 | 0.250 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 22 | 2000 | 3871 | 0.250 |
Why?
|
Polymerase Chain Reaction | 9 | 2015 | 6172 | 0.250 |
Why?
|
Metapneumovirus | 1 | 2004 | 23 | 0.240 |
Why?
|
Fluorescent Antibody Technique | 18 | 1991 | 2505 | 0.240 |
Why?
|
Child | 87 | 2019 | 77679 | 0.230 |
Why?
|
Gene Products, gag | 8 | 2006 | 337 | 0.220 |
Why?
|
HIV Antibodies | 6 | 1996 | 1322 | 0.220 |
Why?
|
Respirovirus | 5 | 1987 | 31 | 0.210 |
Why?
|
Influenza, Human | 9 | 2000 | 1480 | 0.210 |
Why?
|
Cytomegalovirus Infections | 3 | 1999 | 821 | 0.210 |
Why?
|
Humans | 227 | 2022 | 744220 | 0.210 |
Why?
|
Protein Deficiency | 2 | 1992 | 61 | 0.210 |
Why?
|
Rhinovirus | 4 | 1999 | 187 | 0.200 |
Why?
|
Anti-Infective Agents | 4 | 2013 | 972 | 0.200 |
Why?
|
Lamivudine | 4 | 2010 | 342 | 0.200 |
Why?
|
Breast Feeding | 3 | 2017 | 1339 | 0.200 |
Why?
|
Thailand | 11 | 2015 | 296 | 0.200 |
Why?
|
Central Nervous System | 1 | 2009 | 1357 | 0.200 |
Why?
|
Immunoglobulin A | 8 | 2000 | 992 | 0.190 |
Why?
|
DNA, Viral | 8 | 2015 | 2226 | 0.190 |
Why?
|
Influenza Vaccines | 7 | 2000 | 738 | 0.190 |
Why?
|
Viral Proteins | 12 | 2001 | 1900 | 0.190 |
Why?
|
CD4-Positive T-Lymphocytes | 8 | 2008 | 4385 | 0.190 |
Why?
|
Infant Formula | 2 | 2016 | 199 | 0.190 |
Why?
|
Antitubercular Agents | 1 | 2008 | 1320 | 0.180 |
Why?
|
Measles Vaccine | 4 | 1995 | 76 | 0.180 |
Why?
|
Pneumocystis Infections | 1 | 1999 | 10 | 0.180 |
Why?
|
Pneumocystis | 1 | 1999 | 57 | 0.180 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2005 | 546 | 0.180 |
Why?
|
Growth | 5 | 2006 | 376 | 0.180 |
Why?
|
Antigens, CD20 | 1 | 2000 | 199 | 0.180 |
Why?
|
Antibiotic Prophylaxis | 1 | 2004 | 638 | 0.170 |
Why?
|
Nasal Mucosa | 6 | 1985 | 373 | 0.170 |
Why?
|
Pneumonia, Pneumocystis | 3 | 2001 | 249 | 0.170 |
Why?
|
Protein-Energy Malnutrition | 2 | 1991 | 187 | 0.170 |
Why?
|
Ribonucleosides | 3 | 1990 | 82 | 0.170 |
Why?
|
Mediastinal Diseases | 1 | 1999 | 89 | 0.170 |
Why?
|
Ribavirin | 4 | 1990 | 395 | 0.160 |
Why?
|
Bronchiolitis, Viral | 5 | 1981 | 74 | 0.160 |
Why?
|
Therapeutic Human Experimentation | 1 | 1998 | 43 | 0.160 |
Why?
|
Immunoglobulins | 3 | 2000 | 881 | 0.160 |
Why?
|
Pregnancy | 37 | 2017 | 29142 | 0.160 |
Why?
|
Epitopes, T-Lymphocyte | 6 | 2005 | 880 | 0.160 |
Why?
|
Foscarnet | 1 | 1997 | 38 | 0.150 |
Why?
|
Antigens, CD19 | 1 | 2000 | 380 | 0.150 |
Why?
|
Female | 114 | 2017 | 380197 | 0.150 |
Why?
|
Retinitis | 1 | 1997 | 35 | 0.150 |
Why?
|
Erythema Infectiosum | 1 | 1997 | 15 | 0.150 |
Why?
|
Encephalitis, Viral | 1 | 1997 | 55 | 0.150 |
Why?
|
Immunoenzyme Techniques | 5 | 2000 | 1799 | 0.150 |
Why?
|
Ganciclovir | 1 | 1997 | 258 | 0.140 |
Why?
|
Nurseries, Hospital | 2 | 1988 | 17 | 0.140 |
Why?
|
Mesoderm | 1 | 2000 | 686 | 0.140 |
Why?
|
Drug Therapy, Combination | 12 | 2009 | 6485 | 0.140 |
Why?
|
Respiratory System | 5 | 2016 | 557 | 0.140 |
Why?
|
Measles virus | 3 | 1995 | 68 | 0.140 |
Why?
|
Diarrhea, Infantile | 1 | 2016 | 109 | 0.140 |
Why?
|
Tuberculosis | 1 | 2008 | 1912 | 0.130 |
Why?
|
Fatigue Syndrome, Chronic | 1 | 1997 | 214 | 0.130 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1999 | 1155 | 0.130 |
Why?
|
Respiratory Syncytial Virus Infections | 3 | 2000 | 329 | 0.130 |
Why?
|
Vaccination | 9 | 1995 | 3278 | 0.120 |
Why?
|
Drug Resistance, Viral | 2 | 2010 | 820 | 0.120 |
Why?
|
Immunization, Passive | 2 | 1993 | 625 | 0.120 |
Why?
|
Culture Techniques | 12 | 1983 | 554 | 0.120 |
Why?
|
Pregnant Women | 1 | 1998 | 568 | 0.120 |
Why?
|
Parvoviridae Infections | 2 | 2006 | 35 | 0.110 |
Why?
|
Adolescent | 44 | 2009 | 85759 | 0.110 |
Why?
|
Anti-Bacterial Agents | 3 | 2019 | 7179 | 0.110 |
Why?
|
Middle East | 1 | 2013 | 219 | 0.110 |
Why?
|
Blood | 2 | 1994 | 598 | 0.110 |
Why?
|
Cross Infection | 4 | 1988 | 1416 | 0.110 |
Why?
|
Viral Vaccines | 5 | 1993 | 636 | 0.110 |
Why?
|
Infant, Newborn, Diseases | 5 | 1997 | 582 | 0.110 |
Why?
|
Influenza A virus | 10 | 1983 | 457 | 0.110 |
Why?
|
Neutropenia | 2 | 2017 | 895 | 0.100 |
Why?
|
Parainfluenza Virus 3, Human | 3 | 1987 | 24 | 0.100 |
Why?
|
Immunoglobulins, Intravenous | 2 | 1993 | 658 | 0.100 |
Why?
|
Developing Countries | 4 | 1998 | 2814 | 0.100 |
Why?
|
Pneumonia, Viral | 7 | 1992 | 3239 | 0.100 |
Why?
|
Male | 77 | 2013 | 350027 | 0.100 |
Why?
|
Receptors, CCR5 | 2 | 2006 | 497 | 0.100 |
Why?
|
Syphilis, Congenital | 1 | 1990 | 24 | 0.100 |
Why?
|
Nasopharynx | 7 | 1986 | 379 | 0.100 |
Why?
|
Neutralization Tests | 15 | 1992 | 758 | 0.090 |
Why?
|
Asthma | 10 | 2008 | 6011 | 0.090 |
Why?
|
Antiviral Agents | 3 | 1997 | 2987 | 0.090 |
Why?
|
HIV Antigens | 4 | 2001 | 347 | 0.090 |
Why?
|
Picornaviridae Infections | 2 | 1992 | 88 | 0.090 |
Why?
|
Enteral Nutrition | 1 | 1995 | 763 | 0.090 |
Why?
|
Prenatal Exposure Delayed Effects | 4 | 2009 | 2408 | 0.090 |
Why?
|
Virus Cultivation | 11 | 1980 | 92 | 0.090 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2005 | 1368 | 0.090 |
Why?
|
Smallpox Vaccine | 7 | 1977 | 80 | 0.090 |
Why?
|
Lymphocyte Count | 5 | 2008 | 793 | 0.080 |
Why?
|
Disease Outbreaks | 3 | 1989 | 1772 | 0.080 |
Why?
|
Adult | 52 | 2017 | 214035 | 0.080 |
Why?
|
Anti-Retroviral Agents | 4 | 2006 | 1715 | 0.080 |
Why?
|
Otorhinolaryngologic Diseases | 1 | 1989 | 90 | 0.080 |
Why?
|
Health Occupations | 1 | 1990 | 224 | 0.080 |
Why?
|
Orthomyxoviridae | 2 | 2000 | 156 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2019 | 3778 | 0.080 |
Why?
|
Zalcitabine | 2 | 1997 | 42 | 0.080 |
Why?
|
Lymphocyte Subsets | 3 | 2000 | 315 | 0.080 |
Why?
|
Vaccinia virus | 5 | 1978 | 349 | 0.080 |
Why?
|
Mental Processes | 1 | 2009 | 249 | 0.080 |
Why?
|
Herpesvirus 3, Human | 3 | 1984 | 204 | 0.080 |
Why?
|
Severity of Illness Index | 3 | 2013 | 15538 | 0.070 |
Why?
|
Cohort Studies | 14 | 2009 | 40559 | 0.070 |
Why?
|
Drug Administration Schedule | 6 | 2002 | 4929 | 0.070 |
Why?
|
Botswana | 3 | 2017 | 1040 | 0.070 |
Why?
|
Immunity, Cellular | 7 | 2000 | 1607 | 0.070 |
Why?
|
Mastitis | 1 | 1986 | 41 | 0.070 |
Why?
|
Stem Cells | 1 | 2000 | 3567 | 0.070 |
Why?
|
Adenoviridae | 5 | 1983 | 1099 | 0.070 |
Why?
|
Measles | 3 | 1995 | 168 | 0.070 |
Why?
|
Virology | 2 | 2003 | 77 | 0.070 |
Why?
|
Lymphocyte Activation | 6 | 2005 | 5523 | 0.070 |
Why?
|
RNA Viruses | 6 | 1980 | 124 | 0.070 |
Why?
|
Protective Clothing | 2 | 1988 | 102 | 0.070 |
Why?
|
Coronavirus 229E, Human | 1 | 2005 | 16 | 0.070 |
Why?
|
Drug Resistance, Microbial | 3 | 2017 | 862 | 0.070 |
Why?
|
Disease Progression | 11 | 2006 | 13280 | 0.070 |
Why?
|
Indinavir | 1 | 2005 | 74 | 0.060 |
Why?
|
Acute Disease | 4 | 2004 | 7148 | 0.060 |
Why?
|
Serotyping | 6 | 1986 | 338 | 0.060 |
Why?
|
South Africa | 2 | 2008 | 1731 | 0.060 |
Why?
|
Anemia | 2 | 2013 | 1504 | 0.060 |
Why?
|
Substance Abuse, Intravenous | 1 | 2010 | 525 | 0.060 |
Why?
|
Vaccines, Attenuated | 5 | 1984 | 342 | 0.060 |
Why?
|
Herpesvirus 4, Human | 3 | 1999 | 1043 | 0.060 |
Why?
|
Prospective Studies | 15 | 2013 | 53280 | 0.060 |
Why?
|
Pancreatitis | 1 | 1992 | 1091 | 0.060 |
Why?
|
Seasons | 5 | 2004 | 1494 | 0.060 |
Why?
|
Paramyxoviridae | 1 | 2004 | 9 | 0.060 |
Why?
|
DNA, Mitochondrial | 1 | 2009 | 817 | 0.060 |
Why?
|
Coxsackievirus Infections | 2 | 2002 | 44 | 0.060 |
Why?
|
Bacterial Infections | 5 | 1979 | 1401 | 0.060 |
Why?
|
Bronchitis | 5 | 1985 | 201 | 0.060 |
Why?
|
Monocytes | 3 | 2009 | 2594 | 0.060 |
Why?
|
Immunologic Deficiency Syndromes | 3 | 1984 | 547 | 0.060 |
Why?
|
Child Behavior Disorders | 2 | 2006 | 807 | 0.060 |
Why?
|
HIV Long-Term Survivors | 1 | 2004 | 126 | 0.060 |
Why?
|
Communicable Diseases, Emerging | 1 | 2005 | 157 | 0.060 |
Why?
|
Chickenpox | 1 | 1984 | 131 | 0.060 |
Why?
|
Immunoglobulin A, Secretory | 2 | 1980 | 103 | 0.060 |
Why?
|
Time Factors | 17 | 2005 | 40063 | 0.060 |
Why?
|
Serologic Tests | 4 | 1993 | 374 | 0.060 |
Why?
|
HLA-B Antigens | 2 | 2005 | 353 | 0.060 |
Why?
|
Interferon Type I | 1 | 1987 | 542 | 0.060 |
Why?
|
Immunodominant Epitopes | 2 | 2004 | 267 | 0.060 |
Why?
|
Leukocytes | 1 | 1991 | 2040 | 0.060 |
Why?
|
Receptors, Cholinergic | 2 | 1998 | 238 | 0.060 |
Why?
|
Vaccines | 2 | 1989 | 822 | 0.050 |
Why?
|
Genome, Viral | 1 | 2006 | 667 | 0.050 |
Why?
|
Polymorphism, Genetic | 2 | 2006 | 4328 | 0.050 |
Why?
|
Immune Sera | 6 | 1989 | 641 | 0.050 |
Why?
|
Herpesviridae Infections | 3 | 1999 | 277 | 0.050 |
Why?
|
Otolaryngology | 1 | 1989 | 645 | 0.050 |
Why?
|
Fetal Diseases | 1 | 2007 | 903 | 0.050 |
Why?
|
Complement Fixation Tests | 9 | 1978 | 78 | 0.050 |
Why?
|
Virus Shedding | 2 | 1999 | 108 | 0.050 |
Why?
|
Motor Skills | 1 | 2005 | 522 | 0.050 |
Why?
|
Occupational Diseases | 1 | 1990 | 1472 | 0.050 |
Why?
|
Enterovirus | 2 | 1979 | 64 | 0.050 |
Why?
|
Myasthenia Gravis | 2 | 1998 | 201 | 0.050 |
Why?
|
HLA-A2 Antigen | 1 | 2001 | 213 | 0.050 |
Why?
|
Parainfluenza Virus 2, Human | 1 | 1980 | 8 | 0.050 |
Why?
|
Legionnaires' Disease | 1 | 1981 | 48 | 0.050 |
Why?
|
Reye Syndrome | 1 | 1980 | 28 | 0.050 |
Why?
|
Epitopes | 6 | 2003 | 2571 | 0.050 |
Why?
|
Double-Blind Method | 6 | 2017 | 12035 | 0.050 |
Why?
|
Mutation, Missense | 1 | 2010 | 2563 | 0.050 |
Why?
|
Virus Replication | 7 | 2005 | 2534 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2009 | 1901 | 0.050 |
Why?
|
Animals | 27 | 2013 | 168788 | 0.050 |
Why?
|
Vaccines, Conjugate | 1 | 2002 | 333 | 0.050 |
Why?
|
History, 20th Century | 2 | 2005 | 2739 | 0.050 |
Why?
|
Nucleosides | 1 | 2000 | 138 | 0.040 |
Why?
|
Tissue Preservation | 1 | 1980 | 182 | 0.040 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 1981 | 305 | 0.040 |
Why?
|
Survival Rate | 4 | 2000 | 12781 | 0.040 |
Why?
|
Child Health Services | 1 | 1985 | 667 | 0.040 |
Why?
|
Immunoglobulin G | 10 | 2000 | 4559 | 0.040 |
Why?
|
Hepatitis C | 1 | 2010 | 1591 | 0.040 |
Why?
|
Personnel, Hospital | 1 | 1981 | 283 | 0.040 |
Why?
|
Sensitivity and Specificity | 5 | 2005 | 14726 | 0.040 |
Why?
|
Masks | 1 | 1981 | 197 | 0.040 |
Why?
|
B-Lymphocyte Subsets | 1 | 2000 | 246 | 0.040 |
Why?
|
Postpartum Period | 3 | 2010 | 1086 | 0.040 |
Why?
|
Algorithms | 1 | 2019 | 13885 | 0.040 |
Why?
|
Viral Envelope Proteins | 3 | 1988 | 635 | 0.040 |
Why?
|
Parvovirus B19, Human | 1 | 1998 | 38 | 0.040 |
Why?
|
Mice, Inbred BALB C | 4 | 1992 | 6386 | 0.040 |
Why?
|
Lymphadenitis | 1 | 1999 | 98 | 0.040 |
Why?
|
Immunoglobulin M | 6 | 2000 | 1538 | 0.040 |
Why?
|
Cognition | 3 | 2006 | 6765 | 0.040 |
Why?
|
Haemophilus Infections | 3 | 1976 | 95 | 0.040 |
Why?
|
Cytopathogenic Effect, Viral | 5 | 1989 | 156 | 0.040 |
Why?
|
Hepatitis, Viral, Human | 1 | 1998 | 138 | 0.040 |
Why?
|
Pneumococcal Vaccines | 1 | 2002 | 391 | 0.040 |
Why?
|
Body Composition | 2 | 2001 | 2400 | 0.040 |
Why?
|
Amino Acid Sequence | 8 | 2004 | 13817 | 0.040 |
Why?
|
Community-Acquired Infections | 1 | 2002 | 464 | 0.040 |
Why?
|
Cross Reactions | 4 | 1988 | 841 | 0.040 |
Why?
|
Neopterin | 1 | 1997 | 56 | 0.040 |
Why?
|
Trachea | 4 | 1978 | 1075 | 0.040 |
Why?
|
Lung | 5 | 1992 | 9852 | 0.040 |
Why?
|
Viruses | 4 | 1984 | 374 | 0.040 |
Why?
|
Developmental Disabilities | 1 | 2006 | 1456 | 0.040 |
Why?
|
Meningitis, Haemophilus | 1 | 1976 | 21 | 0.040 |
Why?
|
Streptomycin | 1 | 1976 | 69 | 0.040 |
Why?
|
Blood Stains | 1 | 1996 | 8 | 0.040 |
Why?
|
Blotting, Western | 2 | 1998 | 5180 | 0.040 |
Why?
|
Chlamydia Infections | 2 | 1984 | 365 | 0.040 |
Why?
|
Receptors, Chemokine | 1 | 1999 | 669 | 0.040 |
Why?
|
Tumor Virus Infections | 1 | 1999 | 452 | 0.030 |
Why?
|
Bone Marrow Cells | 3 | 2000 | 2513 | 0.030 |
Why?
|
HIV Envelope Protein gp41 | 2 | 2000 | 314 | 0.030 |
Why?
|
Radiography, Thoracic | 2 | 2000 | 1265 | 0.030 |
Why?
|
Enterovirus Infections | 1 | 1976 | 72 | 0.030 |
Why?
|
Regression Analysis | 3 | 2002 | 6461 | 0.030 |
Why?
|
Cartilage | 1 | 2000 | 818 | 0.030 |
Why?
|
Myositis | 1 | 1998 | 251 | 0.030 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 3 | 2001 | 222 | 0.030 |
Why?
|
Species Specificity | 3 | 1998 | 2480 | 0.030 |
Why?
|
Microscopy, Electron | 8 | 1983 | 2645 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4752 | 0.030 |
Why?
|
Blood Preservation | 1 | 1996 | 177 | 0.030 |
Why?
|
Apnea | 1 | 1977 | 195 | 0.030 |
Why?
|
Antibodies, Monoclonal | 8 | 1988 | 9275 | 0.030 |
Why?
|
Cardiomyopathies | 2 | 2002 | 1913 | 0.030 |
Why?
|
Ethics, Medical | 2 | 1998 | 792 | 0.030 |
Why?
|
Sampling Studies | 1 | 1996 | 623 | 0.030 |
Why?
|
Puerto Rico | 1 | 1996 | 356 | 0.030 |
Why?
|
Ventricular Function, Left | 2 | 2000 | 3669 | 0.030 |
Why?
|
Age Distribution | 2 | 2002 | 2903 | 0.030 |
Why?
|
Viral Core Proteins | 3 | 1991 | 162 | 0.030 |
Why?
|
Area Under Curve | 3 | 2005 | 1655 | 0.030 |
Why?
|
Peptides | 2 | 1985 | 4407 | 0.030 |
Why?
|
Molecular Sequence Data | 7 | 2004 | 18116 | 0.030 |
Why?
|
Survival Analysis | 1 | 2008 | 10250 | 0.030 |
Why?
|
National Institutes of Health (U.S.) | 1 | 1978 | 780 | 0.030 |
Why?
|
Viruses, Unclassified | 3 | 1969 | 19 | 0.030 |
Why?
|
Pregnancy Trimester, Third | 2 | 2009 | 571 | 0.030 |
Why?
|
Interferons | 1 | 1978 | 706 | 0.030 |
Why?
|
Coculture Techniques | 1 | 1998 | 1341 | 0.030 |
Why?
|
Hemagglutination Inhibition Tests | 6 | 1983 | 77 | 0.030 |
Why?
|
Antibody Formation | 9 | 1988 | 1402 | 0.030 |
Why?
|
Stromal Cells | 1 | 2000 | 1355 | 0.030 |
Why?
|
Radioimmunoassay | 3 | 1980 | 918 | 0.030 |
Why?
|
Blood-Borne Pathogens | 1 | 1994 | 52 | 0.030 |
Why?
|
Placebos | 2 | 2015 | 1677 | 0.030 |
Why?
|
Pneumococcal Infections | 2 | 1996 | 497 | 0.030 |
Why?
|
Maternal-Fetal Exchange | 2 | 1990 | 455 | 0.030 |
Why?
|
False Positive Reactions | 1 | 1996 | 981 | 0.030 |
Why?
|
Immunization | 3 | 1980 | 1256 | 0.030 |
Why?
|
Evaluation Studies as Topic | 3 | 1990 | 1676 | 0.030 |
Why?
|
Leucine Zippers | 1 | 1993 | 117 | 0.030 |
Why?
|
Aerosols | 2 | 1987 | 623 | 0.030 |
Why?
|
Chemoprevention | 1 | 2015 | 319 | 0.030 |
Why?
|
Bronchiolitis | 2 | 1991 | 458 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1998 | 1475 | 0.030 |
Why?
|
Treatment Outcome | 6 | 2015 | 63119 | 0.030 |
Why?
|
HLA-B27 Antigen | 2 | 2004 | 76 | 0.030 |
Why?
|
Follow-Up Studies | 8 | 2008 | 39045 | 0.030 |
Why?
|
Parotitis | 1 | 1972 | 29 | 0.030 |
Why?
|
gamma-Globulins | 1 | 1972 | 124 | 0.030 |
Why?
|
Internationality | 1 | 1998 | 1003 | 0.030 |
Why?
|
Hospitalization | 3 | 2017 | 10262 | 0.030 |
Why?
|
Longitudinal Studies | 4 | 2009 | 13990 | 0.030 |
Why?
|
Cells, Cultured | 4 | 2000 | 19227 | 0.030 |
Why?
|
Clinical Protocols | 1 | 1998 | 1462 | 0.030 |
Why?
|
Risk Factors | 11 | 2010 | 72280 | 0.030 |
Why?
|
Antigens, Surface | 3 | 1989 | 1663 | 0.030 |
Why?
|
Counterimmunoelectrophoresis | 3 | 1984 | 15 | 0.030 |
Why?
|
Energy Intake | 2 | 2001 | 2148 | 0.030 |
Why?
|
Heart Ventricles | 3 | 2000 | 3820 | 0.030 |
Why?
|
Amylases | 1 | 1992 | 173 | 0.030 |
Why?
|
Opportunistic Infections | 2 | 1992 | 389 | 0.030 |
Why?
|
Autoimmune Diseases | 2 | 1998 | 2136 | 0.030 |
Why?
|
Boston | 4 | 2000 | 9311 | 0.030 |
Why?
|
Antibody Specificity | 3 | 1998 | 1095 | 0.020 |
Why?
|
Colorado | 3 | 1980 | 163 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 1 | 1998 | 1836 | 0.020 |
Why?
|
Murine hepatitis virus | 4 | 1974 | 20 | 0.020 |
Why?
|
Human Experimentation | 1 | 1992 | 127 | 0.020 |
Why?
|
Flow Cytometry | 4 | 2005 | 5974 | 0.020 |
Why?
|
Freezing | 2 | 1982 | 303 | 0.020 |
Why?
|
Subacute Sclerosing Panencephalitis | 2 | 1989 | 24 | 0.020 |
Why?
|
Ligase Chain Reaction | 1 | 2010 | 8 | 0.020 |
Why?
|
Bone Marrow Transplantation | 3 | 1992 | 2763 | 0.020 |
Why?
|
Terminology as Topic | 1 | 1998 | 1548 | 0.020 |
Why?
|
Malabsorption Syndromes | 1 | 1991 | 135 | 0.020 |
Why?
|
United States | 10 | 2008 | 69867 | 0.020 |
Why?
|
Feces | 1 | 2016 | 1402 | 0.020 |
Why?
|
Tablets | 1 | 2010 | 147 | 0.020 |
Why?
|
Multiple Sclerosis | 4 | 1978 | 3079 | 0.020 |
Why?
|
Nutrition Disorders | 1 | 1991 | 211 | 0.020 |
Why?
|
Lung Diseases, Interstitial | 1 | 1998 | 808 | 0.020 |
Why?
|
HIV Envelope Protein gp120 | 1 | 1995 | 952 | 0.020 |
Why?
|
Didanosine | 1 | 2010 | 153 | 0.020 |
Why?
|
Carbohydrate Metabolism | 1 | 1991 | 264 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2008 | 12355 | 0.020 |
Why?
|
Disease Models, Animal | 6 | 1992 | 18027 | 0.020 |
Why?
|
Body Weight | 3 | 2006 | 4666 | 0.020 |
Why?
|
Glycoproteins | 3 | 1988 | 2263 | 0.020 |
Why?
|
Hepatitis C Antibodies | 1 | 2010 | 145 | 0.020 |
Why?
|
Lipase | 1 | 1992 | 315 | 0.020 |
Why?
|
Hemagglutination Tests | 2 | 1980 | 75 | 0.020 |
Why?
|
Poliovirus Vaccine, Inactivated | 1 | 1989 | 24 | 0.020 |
Why?
|
Diphtheria Toxoid | 1 | 1989 | 28 | 0.020 |
Why?
|
Epidemiologic Methods | 2 | 1985 | 1365 | 0.020 |
Why?
|
Methods | 4 | 1984 | 1128 | 0.020 |
Why?
|
Pertussis Vaccine | 1 | 1989 | 34 | 0.020 |
Why?
|
Retroviruses, Simian | 1 | 1989 | 12 | 0.020 |
Why?
|
Sexual Partners | 1 | 1994 | 730 | 0.020 |
Why?
|
Mice | 11 | 1998 | 81178 | 0.020 |
Why?
|
Autoantibodies | 1 | 1998 | 2038 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 1996 | 15070 | 0.020 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 1991 | 767 | 0.020 |
Why?
|
Pharyngitis | 2 | 1985 | 215 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 1992 | 675 | 0.020 |
Why?
|
Diphtheria-Tetanus-Pertussis Vaccine | 1 | 1989 | 56 | 0.020 |
Why?
|
Specimen Handling | 3 | 1998 | 694 | 0.020 |
Why?
|
AIDS Serodiagnosis | 1 | 1990 | 184 | 0.020 |
Why?
|
Labor, Obstetric | 2 | 2004 | 333 | 0.020 |
Why?
|
Histocompatibility Testing | 2 | 2001 | 742 | 0.020 |
Why?
|
Myocardial Contraction | 1 | 1994 | 1585 | 0.020 |
Why?
|
Erythema | 4 | 1977 | 257 | 0.020 |
Why?
|
HN Protein | 1 | 1988 | 8 | 0.020 |
Why?
|
Incidence | 3 | 2008 | 20945 | 0.020 |
Why?
|
Ampicillin | 4 | 1976 | 138 | 0.020 |
Why?
|
Bone and Bones | 1 | 2000 | 2575 | 0.020 |
Why?
|
Tetanus Toxoid | 1 | 1989 | 193 | 0.020 |
Why?
|
Hypersensitivity | 1 | 1977 | 1102 | 0.020 |
Why?
|
Viral Fusion Proteins | 2 | 1987 | 95 | 0.020 |
Why?
|
Hypersensitivity, Delayed | 1 | 1989 | 485 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2005 | 7281 | 0.020 |
Why?
|
Retrospective Studies | 7 | 2006 | 77426 | 0.020 |
Why?
|
Gloves, Surgical | 1 | 1988 | 26 | 0.020 |
Why?
|
Administration, Oral | 3 | 2010 | 3913 | 0.020 |
Why?
|
HIV-2 | 1 | 1989 | 167 | 0.020 |
Why?
|
Visitors to Patients | 1 | 1988 | 35 | 0.020 |
Why?
|
Respiratory Protective Devices | 1 | 1988 | 45 | 0.020 |
Why?
|
Heart | 2 | 1992 | 4465 | 0.020 |
Why?
|
Bacteria | 2 | 2016 | 2114 | 0.020 |
Why?
|
Bronchi | 1 | 1992 | 840 | 0.020 |
Why?
|
Cell Line | 9 | 2002 | 15999 | 0.020 |
Why?
|
Drug Interactions | 2 | 2004 | 1458 | 0.020 |
Why?
|
Myocardium | 2 | 1992 | 4776 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2000 | 3278 | 0.020 |
Why?
|
Weight Gain | 2 | 1995 | 2292 | 0.020 |
Why?
|
Diet, Reducing | 1 | 1991 | 462 | 0.020 |
Why?
|
Leukocyte Count | 1 | 1991 | 1584 | 0.020 |
Why?
|
Gestational Age | 3 | 2004 | 3493 | 0.020 |
Why?
|
Cardiovascular Diseases | 2 | 1993 | 15161 | 0.020 |
Why?
|
New Jersey | 2 | 1977 | 290 | 0.020 |
Why?
|
Haplorhini | 4 | 1979 | 552 | 0.020 |
Why?
|
Health Policy | 1 | 2000 | 2661 | 0.020 |
Why?
|
Echocardiography | 4 | 1998 | 5103 | 0.020 |
Why?
|
Plasma | 1 | 2010 | 575 | 0.020 |
Why?
|
Risk | 3 | 2001 | 9685 | 0.020 |
Why?
|
Sulfonamides | 1 | 1976 | 1940 | 0.020 |
Why?
|
Injections, Intradermal | 5 | 1977 | 117 | 0.020 |
Why?
|
Mutation | 5 | 2005 | 29784 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 1998 | 2072 | 0.020 |
Why?
|
Neutrophils | 2 | 2006 | 3717 | 0.020 |
Why?
|
Heart Arrest | 2 | 1994 | 1470 | 0.020 |
Why?
|
Dietary Proteins | 1 | 1992 | 963 | 0.020 |
Why?
|
Lymphoid Tissue | 1 | 1988 | 455 | 0.020 |
Why?
|
Immunophenotyping | 2 | 2005 | 1880 | 0.020 |
Why?
|
Immunocompromised Host | 1 | 1992 | 847 | 0.020 |
Why?
|
Thiocyanates | 1 | 1986 | 70 | 0.020 |
Why?
|
Cytomegalovirus | 3 | 1998 | 732 | 0.020 |
Why?
|
Pediatrics | 1 | 1981 | 3469 | 0.020 |
Why?
|
Time | 1 | 2008 | 541 | 0.020 |
Why?
|
AIDS Dementia Complex | 2 | 1998 | 153 | 0.020 |
Why?
|
Linear Models | 1 | 1996 | 5953 | 0.020 |
Why?
|
Fluoresceins | 1 | 1986 | 235 | 0.020 |
Why?
|
Nucleoproteins | 2 | 1985 | 115 | 0.020 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 1986 | 225 | 0.020 |
Why?
|
Tonsillitis | 1 | 1985 | 30 | 0.020 |
Why?
|
Tracheitis | 1 | 1985 | 28 | 0.020 |
Why?
|
Antigen-Antibody Reactions | 2 | 1980 | 363 | 0.020 |
Why?
|
Clinical Trials as Topic | 3 | 1998 | 7908 | 0.020 |
Why?
|
Canada | 1 | 1991 | 2065 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2006 | 402 | 0.020 |
Why?
|
Haemophilus influenzae | 2 | 1976 | 171 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 1986 | 462 | 0.020 |
Why?
|
Variola virus | 4 | 1977 | 11 | 0.020 |
Why?
|
Physicians' Offices | 1 | 1985 | 58 | 0.020 |
Why?
|
Molecular Weight | 3 | 1988 | 2255 | 0.020 |
Why?
|
Receptors, Virus | 1 | 1989 | 648 | 0.020 |
Why?
|
Respiratory Insufficiency | 1 | 1994 | 1199 | 0.020 |
Why?
|
Drug Hypersensitivity | 1 | 1994 | 883 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2010 | 2032 | 0.020 |
Why?
|
Escherichia coli | 1 | 2017 | 4220 | 0.020 |
Why?
|
Serum Albumin | 1 | 2008 | 676 | 0.020 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1984 | 60 | 0.020 |
Why?
|
Fever | 3 | 1994 | 1614 | 0.020 |
Why?
|
Quality of Life | 1 | 2006 | 12805 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 3 | 1983 | 370 | 0.020 |
Why?
|
Antigens | 2 | 1971 | 1466 | 0.020 |
Why?
|
Vocabulary | 1 | 2005 | 169 | 0.020 |
Why?
|
Simian immunodeficiency virus | 1 | 1989 | 846 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 1991 | 1782 | 0.010 |
Why?
|
Intubation | 1 | 1984 | 141 | 0.010 |
Why?
|
Muscles | 1 | 1989 | 1622 | 0.010 |
Why?
|
Drug Combinations | 1 | 1989 | 1962 | 0.010 |
Why?
|
Parturition | 1 | 2007 | 441 | 0.010 |
Why?
|
Interferon-gamma | 2 | 2003 | 3203 | 0.010 |
Why?
|
Metabolic Clearance Rate | 1 | 2004 | 379 | 0.010 |
Why?
|
Analysis of Variance | 2 | 2007 | 6367 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 1992 | 1838 | 0.010 |
Why?
|
Electrocardiography | 3 | 1994 | 6442 | 0.010 |
Why?
|
Urine | 2 | 1998 | 370 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 2 | 2000 | 329 | 0.010 |
Why?
|
Half-Life | 1 | 2004 | 659 | 0.010 |
Why?
|
Anthropometry | 2 | 2001 | 1350 | 0.010 |
Why?
|
Respiration | 2 | 2000 | 1651 | 0.010 |
Why?
|
Biological Products | 1 | 1992 | 860 | 0.010 |
Why?
|
Immunologic Techniques | 1 | 1983 | 218 | 0.010 |
Why?
|
Culture Media | 3 | 1988 | 908 | 0.010 |
Why?
|
Phenotype | 2 | 2002 | 16365 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2000 | 11478 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 1971 | 1888 | 0.010 |
Why?
|
Hepacivirus | 1 | 2010 | 1379 | 0.010 |
Why?
|
Reference Values | 1 | 2009 | 4982 | 0.010 |
Why?
|
Multivariate Analysis | 3 | 2002 | 12244 | 0.010 |
Why?
|
Biological Evolution | 1 | 2008 | 1076 | 0.010 |
Why?
|
Antibodies, Bacterial | 2 | 1981 | 1470 | 0.010 |
Why?
|
Pregnancy Outcome | 2 | 2004 | 2796 | 0.010 |
Why?
|
Mycoplasma Infections | 2 | 1979 | 118 | 0.010 |
Why?
|
Adenosine Deaminase | 1 | 1984 | 241 | 0.010 |
Why?
|
Giant Cells | 1 | 2002 | 187 | 0.010 |
Why?
|
Colostrum | 1 | 1981 | 28 | 0.010 |
Why?
|
Rifabutin | 1 | 2001 | 52 | 0.010 |
Why?
|
Young Adult | 3 | 2015 | 56436 | 0.010 |
Why?
|
Antigenic Variation | 1 | 2001 | 125 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 1989 | 1737 | 0.010 |
Why?
|
Gastrointestinal Diseases | 2 | 1991 | 1169 | 0.010 |
Why?
|
Infant Mortality | 1 | 2006 | 754 | 0.010 |
Why?
|
Prognosis | 2 | 2005 | 29050 | 0.010 |
Why?
|
Legionella | 1 | 1981 | 30 | 0.010 |
Why?
|
Massachusetts | 2 | 1996 | 8663 | 0.010 |
Why?
|
Acetylcysteine | 1 | 1982 | 272 | 0.010 |
Why?
|
HLA-B7 Antigen | 1 | 2000 | 48 | 0.010 |
Why?
|
Intelligence | 1 | 2006 | 920 | 0.010 |
Why?
|
Antibiotics, Antitubercular | 1 | 2001 | 104 | 0.010 |
Why?
|
Gene Products, nef | 1 | 2000 | 110 | 0.010 |
Why?
|
Antibodies, Heterophile | 1 | 1980 | 126 | 0.010 |
Why?
|
Encephalitis | 2 | 1978 | 423 | 0.010 |
Why?
|
Nose | 1 | 1984 | 509 | 0.010 |
Why?
|
Hemoglobins | 1 | 2006 | 1533 | 0.010 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 2000 | 153 | 0.010 |
Why?
|
Logistic Models | 2 | 2007 | 13409 | 0.010 |
Why?
|
Tetracyclines | 2 | 1976 | 60 | 0.010 |
Why?
|
Sputum | 2 | 1979 | 476 | 0.010 |
Why?
|
Age Factors | 5 | 1999 | 18367 | 0.010 |
Why?
|
Autoradiography | 2 | 1990 | 749 | 0.010 |
Why?
|
Chloramphenicol | 2 | 1976 | 75 | 0.010 |
Why?
|
Immunocompetence | 1 | 1980 | 137 | 0.010 |
Why?
|
Body Height | 1 | 2006 | 1576 | 0.010 |
Why?
|
Complement Activation | 1 | 1981 | 453 | 0.010 |
Why?
|
HIV Reverse Transcriptase | 1 | 2000 | 213 | 0.010 |
Why?
|
CD4-CD8 Ratio | 1 | 1998 | 112 | 0.010 |
Why?
|
Aging | 3 | 2000 | 8661 | 0.010 |
Why?
|
Cryptogenic Organizing Pneumonia | 1 | 1998 | 29 | 0.010 |
Why?
|
Child Behavior | 1 | 2005 | 838 | 0.010 |
Why?
|
Receptors, Cytokine | 1 | 1999 | 261 | 0.010 |
Why?
|
Mitochondria, Heart | 1 | 2000 | 247 | 0.010 |
Why?
|
Receptors, CCR2 | 1 | 1999 | 212 | 0.010 |
Why?
|
DNA Primers | 1 | 2003 | 2892 | 0.010 |
Why?
|
Ventricular Function | 1 | 2000 | 416 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2010 | 4803 | 0.010 |
Why?
|
5' Untranslated Regions | 1 | 1999 | 249 | 0.010 |
Why?
|
Rubella | 1 | 1978 | 48 | 0.010 |
Why?
|
Interviews as Topic | 1 | 1985 | 2539 | 0.010 |
Why?
|
Memory, Short-Term | 1 | 2005 | 975 | 0.010 |
Why?
|
Egg White | 1 | 1977 | 18 | 0.010 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2003 | 986 | 0.010 |
Why?
|
Maximal Midexpiratory Flow Rate | 1 | 1977 | 78 | 0.010 |
Why?
|
Neuropsychological Tests | 2 | 2005 | 6991 | 0.010 |
Why?
|
Oropharynx | 1 | 1998 | 127 | 0.010 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 1998 | 113 | 0.010 |
Why?
|
HIV Seroprevalence | 1 | 1998 | 86 | 0.010 |
Why?
|
Torpedo | 1 | 1998 | 169 | 0.010 |
Why?
|
Herpes Simplex | 2 | 1978 | 470 | 0.010 |
Why?
|
Peptide Fragments | 2 | 2000 | 5096 | 0.010 |
Why?
|
Base Sequence | 2 | 2003 | 12801 | 0.010 |
Why?
|
Rotavirus | 1 | 1978 | 109 | 0.010 |
Why?
|
Perinatal Care | 1 | 1999 | 227 | 0.010 |
Why?
|
Ecology | 1 | 1978 | 106 | 0.010 |
Why?
|
T-Lymphocytes | 2 | 1989 | 10182 | 0.010 |
Why?
|
Clinical Laboratory Techniques | 1 | 1983 | 738 | 0.010 |
Why?
|
ROC Curve | 1 | 2005 | 3527 | 0.010 |
Why?
|
Penicillin Resistance | 1 | 1976 | 83 | 0.010 |
Why?
|
Uterine Hemorrhage | 1 | 1998 | 255 | 0.010 |
Why?
|
Cell Survival | 1 | 1987 | 5881 | 0.010 |
Why?
|
Macaca fascicularis | 1 | 1979 | 910 | 0.010 |
Why?
|
Lymphotoxin-alpha | 1 | 1977 | 96 | 0.010 |
Why?
|
Immunoassay | 1 | 1980 | 752 | 0.010 |
Why?
|
Antibodies | 3 | 1977 | 2461 | 0.010 |
Why?
|
Enterovirus B, Human | 1 | 1976 | 52 | 0.010 |
Why?
|
Sex Distribution | 1 | 2002 | 2297 | 0.010 |
Why?
|
Blood Specimen Collection | 1 | 1998 | 246 | 0.010 |
Why?
|
Hybridomas | 1 | 1998 | 452 | 0.010 |
Why?
|
Milk, Human | 1 | 1981 | 490 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 2006 | 2420 | 0.010 |
Why?
|
Injections, Intramuscular | 1 | 1977 | 548 | 0.010 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 1980 | 459 | 0.010 |
Why?
|
Child, Hospitalized | 1 | 1978 | 174 | 0.010 |
Why?
|
Pharynx | 2 | 1979 | 413 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 2 | 1990 | 1375 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 1987 | 3769 | 0.010 |
Why?
|
Solubility | 2 | 1988 | 1083 | 0.010 |
Why?
|
Adenoviridae Infections | 2 | 1973 | 96 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1999 | 794 | 0.010 |
Why?
|
Ovalbumin | 1 | 1977 | 719 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1999 | 1574 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2006 | 6893 | 0.010 |
Why?
|
Aged | 3 | 2005 | 163253 | 0.010 |
Why?
|
Blood Platelets | 1 | 2006 | 2508 | 0.010 |
Why?
|
Skin Tests | 1 | 1977 | 612 | 0.010 |
Why?
|
Carrier State | 1 | 1979 | 518 | 0.010 |
Why?
|
Environmental Exposure | 1 | 1990 | 4236 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2000 | 1792 | 0.010 |
Why?
|
Genotype | 2 | 2000 | 12956 | 0.010 |
Why?
|
Odds Ratio | 1 | 2007 | 9849 | 0.010 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 1995 | 187 | 0.010 |
Why?
|
Laryngismus | 1 | 1974 | 28 | 0.010 |
Why?
|
Kidney | 4 | 1979 | 7183 | 0.010 |
Why?
|
Linkage Disequilibrium | 1 | 1999 | 1997 | 0.010 |
Why?
|
Phosphorus Isotopes | 2 | 1971 | 126 | 0.010 |
Why?
|
Reference Standards | 1 | 1998 | 1025 | 0.010 |
Why?
|
Centrifugation, Density Gradient | 2 | 1971 | 313 | 0.010 |
Why?
|
Case-Control Studies | 2 | 2002 | 21752 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1998 | 2050 | 0.010 |
Why?
|
Phylogeny | 1 | 2001 | 2803 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1998 | 805 | 0.010 |
Why?
|
Lincomycin | 1 | 1973 | 6 | 0.010 |
Why?
|
Genitalia, Female | 1 | 1975 | 146 | 0.010 |
Why?
|
Pedigree | 1 | 2001 | 4648 | 0.010 |
Why?
|
Bacteroides Infections | 1 | 1973 | 82 | 0.010 |
Why?
|
Isoleucine | 1 | 1993 | 112 | 0.010 |
Why?
|
Lipids | 2 | 1978 | 3305 | 0.010 |
Why?
|
Edetic Acid | 1 | 1973 | 276 | 0.010 |
Why?
|
Organ Culture Techniques | 2 | 1978 | 813 | 0.010 |
Why?
|
Respiratory Function Tests | 1 | 1977 | 1618 | 0.010 |
Why?
|
Frontal Sinus | 1 | 1973 | 50 | 0.010 |
Why?
|
Capsid | 2 | 1987 | 436 | 0.010 |
Why?
|
Pulmonary Atelectasis | 1 | 1974 | 145 | 0.010 |
Why?
|
Mice, Nude | 1 | 1980 | 3689 | 0.010 |
Why?
|
Prenatal Care | 1 | 2000 | 1092 | 0.010 |
Why?
|
Gels | 2 | 1971 | 427 | 0.010 |
Why?
|
Administration, Intranasal | 1 | 1974 | 446 | 0.010 |
Why?
|
Epithelium | 1 | 1978 | 1680 | 0.010 |
Why?
|
Prevalence | 1 | 2010 | 15226 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 1998 | 2236 | 0.010 |
Why?
|
Forced Expiratory Volume | 1 | 1977 | 1744 | 0.010 |
Why?
|
Gene Frequency | 1 | 1999 | 3588 | 0.010 |
Why?
|
Tympanic Membrane | 1 | 1974 | 224 | 0.010 |
Why?
|
Brain Abscess | 1 | 1973 | 118 | 0.010 |
Why?
|
Macaca mulatta | 1 | 1979 | 2378 | 0.010 |
Why?
|
Streptococcal Infections | 2 | 1976 | 638 | 0.010 |
Why?
|
Platelet Adhesiveness | 1 | 1973 | 161 | 0.010 |
Why?
|
Erythropoiesis | 1 | 1976 | 705 | 0.010 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 1973 | 131 | 0.010 |
Why?
|
Inflammation | 1 | 1992 | 10634 | 0.010 |
Why?
|
Antigen Presentation | 1 | 1998 | 1284 | 0.010 |
Why?
|
Temperature | 2 | 1978 | 2206 | 0.010 |
Why?
|
Maxillary Sinus | 1 | 1973 | 180 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 1978 | 12961 | 0.010 |
Why?
|
Xylose | 1 | 1991 | 28 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1973 | 1386 | 0.010 |
Why?
|
Leucine | 1 | 1993 | 561 | 0.010 |
Why?
|
Cesium | 1 | 1971 | 38 | 0.010 |
Why?
|
Lactose Intolerance | 1 | 1991 | 27 | 0.010 |
Why?
|
Tachycardia | 1 | 1994 | 620 | 0.010 |
Why?
|
Brain | 2 | 1989 | 26413 | 0.010 |
Why?
|
Proline | 1 | 1993 | 458 | 0.010 |
Why?
|
Chromatography, Thin Layer | 1 | 1971 | 223 | 0.010 |
Why?
|
Injections, Subcutaneous | 3 | 1977 | 665 | 0.010 |
Why?
|
Dilatation, Pathologic | 1 | 1992 | 520 | 0.010 |
Why?
|
Chromatography, Ion Exchange | 1 | 1971 | 305 | 0.010 |
Why?
|
Infant, Premature, Diseases | 1 | 1977 | 706 | 0.010 |
Why?
|
Cervix Uteri | 1 | 1975 | 590 | 0.010 |
Why?
|
False Negative Reactions | 1 | 1992 | 587 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2006 | 3658 | 0.010 |
Why?
|
Immunization, Secondary | 1 | 1972 | 340 | 0.010 |
Why?
|
Chromatography, Gel | 1 | 1971 | 668 | 0.010 |
Why?
|
Cell Membrane | 1 | 1980 | 3748 | 0.010 |
Why?
|
Hot Temperature | 2 | 1973 | 1355 | 0.010 |
Why?
|
Glycolipids | 1 | 1971 | 205 | 0.010 |
Why?
|
HIV Envelope Protein gp160 | 1 | 1990 | 99 | 0.010 |
Why?
|
Immunoglobulin E | 1 | 1976 | 1463 | 0.010 |
Why?
|
Carbon Isotopes | 1 | 1971 | 469 | 0.010 |
Why?
|
Breath Tests | 1 | 1991 | 279 | 0.010 |
Why?
|
Esters | 1 | 1971 | 210 | 0.010 |
Why?
|
Silicon Dioxide | 1 | 1971 | 213 | 0.010 |
Why?
|
Lymphocytes | 3 | 1992 | 2617 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 1993 | 1246 | 0.010 |
Why?
|
Solvents | 1 | 1971 | 302 | 0.010 |
Why?
|
Blood Donors | 1 | 1992 | 355 | 0.010 |
Why?
|
Chronic Disease | 3 | 2000 | 9147 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1991 | 637 | 0.010 |
Why?
|
Cardiomegaly | 1 | 1992 | 620 | 0.010 |
Why?
|
Acetates | 1 | 1971 | 313 | 0.010 |
Why?
|
Cilia | 2 | 1978 | 466 | 0.010 |
Why?
|
Antigens, CD | 1 | 2000 | 4026 | 0.010 |
Why?
|
Cattle | 2 | 1977 | 3922 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1991 | 376 | 0.010 |
Why?
|
Middle Aged | 8 | 2006 | 213367 | 0.010 |
Why?
|
Fatty Acids, Nonesterified | 1 | 1971 | 402 | 0.010 |
Why?
|
Gene Products, env | 1 | 1990 | 263 | 0.010 |
Why?
|
Antigens, Bacterial | 1 | 1975 | 1171 | 0.010 |
Why?
|
Heart Rate | 1 | 2000 | 4092 | 0.010 |
Why?
|
Alleles | 1 | 1999 | 6938 | 0.010 |
Why?
|
Receptors, HIV | 1 | 1989 | 162 | 0.010 |
Why?
|
Body Mass Index | 1 | 2006 | 12718 | 0.000 |
Why?
|
Chlorides | 1 | 1971 | 667 | 0.000 |
Why?
|
Hypotension | 1 | 1994 | 880 | 0.000 |
Why?
|
Orthomyxoviridae Infections | 1 | 1970 | 248 | 0.000 |
Why?
|
Morbidity | 1 | 1993 | 1769 | 0.000 |
Why?
|
Phosphates | 1 | 1971 | 786 | 0.000 |
Why?
|
Phospholipids | 1 | 1971 | 781 | 0.000 |
Why?
|
Nervous System Diseases | 1 | 1978 | 1623 | 0.000 |
Why?
|
Cell Extracts | 1 | 1987 | 138 | 0.000 |
Why?
|
Convalescence | 1 | 1967 | 105 | 0.000 |
Why?
|
Immunoblotting | 1 | 1990 | 1682 | 0.000 |
Why?
|
Rats, Inbred Lew | 1 | 1988 | 1161 | 0.000 |
Why?
|
Risk Assessment | 1 | 2007 | 23337 | 0.000 |
Why?
|
Growth Disorders | 1 | 1991 | 645 | 0.000 |
Why?
|
Multicenter Studies as Topic | 1 | 1991 | 1677 | 0.000 |
Why?
|
Ultraviolet Rays | 1 | 1971 | 1060 | 0.000 |
Why?
|
Protein Precursors | 1 | 1990 | 1154 | 0.000 |
Why?
|
Immunosuppressive Agents | 1 | 1998 | 4151 | 0.000 |
Why?
|
Deoxyribonuclease EcoRI | 1 | 1984 | 31 | 0.000 |
Why?
|
Complement Activating Enzymes | 1 | 1984 | 28 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2002 | 9960 | 0.000 |
Why?
|
Intestines | 1 | 1974 | 1924 | 0.000 |
Why?
|
Protein Conformation | 1 | 1993 | 4012 | 0.000 |
Why?
|
Clinical Enzyme Tests | 1 | 1984 | 115 | 0.000 |
Why?
|
DNA Restriction Enzymes | 1 | 1984 | 570 | 0.000 |
Why?
|
Complement C1q | 1 | 1984 | 92 | 0.000 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1987 | 1801 | 0.000 |
Why?
|
Heart Diseases | 1 | 1977 | 2790 | 0.000 |
Why?
|
Rabbits | 1 | 1971 | 4892 | 0.000 |
Why?
|
DNA Mutational Analysis | 1 | 1993 | 4188 | 0.000 |
Why?
|
Fibroblasts | 1 | 1974 | 4156 | 0.000 |
Why?
|
Staphylococcal Infections | 1 | 1973 | 1400 | 0.000 |
Why?
|
Herpes Genitalis | 1 | 1984 | 141 | 0.000 |
Why?
|
Arrhythmias, Cardiac | 1 | 1993 | 2267 | 0.000 |
Why?
|
Triglycerides | 1 | 1971 | 2453 | 0.000 |
Why?
|
Chlamydia trachomatis | 1 | 1984 | 246 | 0.000 |
Why?
|
Cholesterol | 1 | 1971 | 2911 | 0.000 |
Why?
|
Complement C3b | 1 | 1981 | 106 | 0.000 |
Why?
|
Immunologic Memory | 1 | 1988 | 1348 | 0.000 |
Why?
|
Cell Fusion | 1 | 1981 | 297 | 0.000 |
Why?
|
Liver | 1 | 1996 | 7472 | 0.000 |
Why?
|
Kinetics | 1 | 1988 | 6474 | 0.000 |
Why?
|
Recombinant Proteins | 1 | 1990 | 6612 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 1998 | 21824 | 0.000 |
Why?
|
Swine | 2 | 1978 | 5940 | 0.000 |
Why?
|
Kentucky | 1 | 1977 | 83 | 0.000 |
Why?
|
Nerve Tissue Proteins | 1 | 1990 | 4465 | 0.000 |
Why?
|
Military Medicine | 1 | 1979 | 176 | 0.000 |
Why?
|
Smallpox | 1 | 1977 | 45 | 0.000 |
Why?
|
Minnesota | 1 | 1977 | 344 | 0.000 |
Why?
|
Transplantation, Homologous | 2 | 1976 | 4776 | 0.000 |
Why?
|
Swine Diseases | 1 | 1976 | 73 | 0.000 |
Why?
|
Remission, Spontaneous | 1 | 1976 | 380 | 0.000 |
Why?
|
Lung Diseases, Fungal | 1 | 1976 | 122 | 0.000 |
Why?
|
Karyotyping | 1 | 1976 | 1243 | 0.000 |
Why?
|
Nitrofurantoin | 1 | 1973 | 19 | 0.000 |
Why?
|
Kanamycin | 1 | 1973 | 64 | 0.000 |
Why?
|
Erythromycin | 1 | 1973 | 120 | 0.000 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 1973 | 69 | 0.000 |
Why?
|
Clindamycin | 1 | 1973 | 139 | 0.000 |
Why?
|
California | 1 | 1977 | 1402 | 0.000 |
Why?
|
Histocompatibility | 1 | 1973 | 330 | 0.000 |
Why?
|
Urticaria | 1 | 1973 | 150 | 0.000 |
Why?
|
Rats | 1 | 1988 | 24273 | 0.000 |
Why?
|
Acrylates | 1 | 1971 | 89 | 0.000 |
Why?
|
Electrophoresis | 1 | 1971 | 240 | 0.000 |
Why?
|
Otitis Media | 1 | 1973 | 277 | 0.000 |
Why?
|
Spectrophotometry | 1 | 1971 | 313 | 0.000 |
Why?
|
World Health Organization | 1 | 1977 | 1318 | 0.000 |
Why?
|
Sucrose | 1 | 1971 | 164 | 0.000 |
Why?
|
Statistics as Topic | 1 | 1977 | 2374 | 0.000 |
Why?
|
Syndrome | 1 | 1976 | 3250 | 0.000 |
Why?
|
Glycerol | 1 | 1971 | 278 | 0.000 |
Why?
|
Deoxyuridine | 1 | 1969 | 33 | 0.000 |
Why?
|
Chloroform | 1 | 1969 | 28 | 0.000 |
Why?
|
Heart Failure | 1 | 1993 | 10905 | 0.000 |
Why?
|
Autopsy | 1 | 1973 | 1021 | 0.000 |
Why?
|
Bile Acids and Salts | 1 | 1971 | 363 | 0.000 |
Why?
|
Nucleic Acids | 1 | 1969 | 182 | 0.000 |
Why?
|
Bone Marrow | 1 | 1976 | 2944 | 0.000 |
Why?
|
Mouth Neoplasms | 1 | 1971 | 601 | 0.000 |
Why?
|
Chick Embryo | 1 | 1967 | 982 | 0.000 |
Why?
|
HeLa Cells | 1 | 1971 | 3129 | 0.000 |
Why?
|
Sinusitis | 1 | 1973 | 923 | 0.000 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1969 | 2557 | 0.000 |
Why?
|
Morphogenesis | 1 | 1967 | 752 | 0.000 |
Why?
|
Public Health | 1 | 1977 | 2603 | 0.000 |
Why?
|
Embryo, Mammalian | 1 | 1969 | 1701 | 0.000 |
Why?
|
Radiography | 1 | 1973 | 7022 | 0.000 |
Why?
|
Carcinoma | 1 | 1971 | 2375 | 0.000 |
Why?
|
Smoking | 1 | 1976 | 8986 | 0.000 |
Why?
|